Preclinical Systolic and Diastolic Dysfunction Assessed by Tissue Doppler Imaging is Associated With Elevated Plasma Pro-B-type Natriuretic Peptide Concentrations

Journal of Cardiac Failure

Volumn 15, Issue 6, 2009, Pages 489-495

  Mogelvang, Rasmus ^a,b   Goetze, Jens P ^c   Pedersen, Sune A ^b   Olsen, Niels T ^b   Marott, Jacob L ^a   Schnohr, Peter ^a   Sogaard, Peter ^b   Jensen, Jan S ^a,b  

^a BISPEBJERG HOSPITAL   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c Rigshospitalet   (Denmark)

Author keywords

diagnosis; echocardiography; Heart failure; population; ProBNP

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; ARTICLE; BLOOD FLOW VELOCITY; BODY MASS; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTROLLED STUDY; CORRELATIONAL STUDY; DIABETES MELLITUS; DIASTOLE; DIASTOLIC DYSFUNCTION; ECHOCARDIOGRAPHY; FEMALE; GENDER; GLOMERULUS FILTRATION RATE; HEART DILATATION; HEART FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART PERFORMANCE; HEART RATE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTOLE; SYSTOLIC DYSFUNCTION; TISSUE DOPPLER IMAGING;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; COHORT STUDIES; DIASTOLE; ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY, DOPPLER, COLOR; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; RESIDENCE CHARACTERISTICS; SYSTOLE;

EID: 67651085588     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2009.01.005     Document Type: Article

References (41)

1. Lloyd-Jones D.M., Larson M.G., Leip E.P., Beiser A., D'Agostino R.B., Kannel W.B., et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation 106 (2002) 3068-3072
2. Stewart S., MacIntyre K., Hole D.J., Capewell S., and McMurray J.J. More 'malignant' than cancer? Five-year survival following a first admission for heart failure. Eur J Heart Fail 3 (2001) 315-322
3. Hunt S.A., Abraham W.T., Chin M.H., Feldman A.M., Francis G.S., Ganiats T.G., et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 112 (2005) e154-e235
4. Swedberg K., Cleland J., Dargie H., Drexler H., Follath F., Komajda M., et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 26 (2005) 1115-1140
5. Redfield M.M., Jacobsen S.J., Burnett Jr. J.C., Mahoney D.W., Bailey K.R., and Rodeheffer R.J. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 289 (2003) 194-202
6. Nikitin N.P., and Witte K.K. Application of tissue Doppler imaging in cardiology. Cardiology 101 (2004) 170-184
7. Yu C.M., Sanderson J.E., Marwick T.H., and Oh J.K. Tissue Doppler imaging a new prognosticator for cardiovascular diseases. J Am Coll Cardiol 49 (2007) 1903-1914
8. Bruch C., Klem I., Breithardt G., Wichter T., and Gradaus R. Diagnostic usefulness and prognostic implications of the mitral E/E' ratio in patients with heart failure and severe secondary mitral regurgitation. Am J Cardiol 100 (2007) 860-865
9. Nikitin N.P., Loh P.H., Silva R., Ghosh J., Khaleva O.Y., Goode K., et al. Prognostic value of systolic mitral annular velocity measured with Doppler tissue imaging in patients with chronic heart failure caused by left ventricular systolic dysfunction. Heart 92 (2006) 775-779
10. Dokainish H., Zoghbi W.A., Lakkis N.M., Ambriz E., Patel R., Quinones M.A., et al. Incremental predictive power of B-type natriuretic peptide and tissue Doppler echocardiography in the prognosis of patients with congestive heart failure. J Am Coll Cardiol 45 (2005) 1223-1226
11. Troughton R.W., Prior D.L., Frampton C.M., Nash P.J., Pereira J.J., Martin M., et al. Usefulness of tissue Doppler and color M-mode indexes of left ventricular diastolic function in predicting outcomes in systolic left ventricular heart failure (from the ADEPT study). Am J Cardiol 96 (2005) 257-262
12. Wang M., Yip G., Yu C.M., Zhang Q., Zhang Y., Tse D., et al. Independent and incremental prognostic value of early mitral annulus velocity in patients with impaired left ventricular systolic function. J Am Coll Cardiol 45 (2005) 272-277
13. Wang T.J., Larson M.G., Levy D., Benjamin E.J., Leip E.P., Omland T., et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 350 (2004) 655-663
14. Appleyard M., Hansen A.T., Schnohr P., Jensen G., and Nyboe J. The Copenhagen City Heart Study. A book of tables with data from the first examination (1976-78) and a five-year follow-up (1981-83). Scand J Soc Med 170 (1989) 1-160
15. Schnohr P., Jensen G., Lange P., Scharling H., and Appleyard M. The Copenhagen City Heart Study. Tables with data from the third examination 1991-94. Eur Heart J 3 (2001) 1-83
16. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo Jr. J.L., et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42 (2003) 1206-1252
17. Peters A.L., Davidson M.B., Schriger D.L., and Hasselblad V. A clinical approach for the diagnosis of diabetes mellitus: an analysis using glycosylated hemoglobin levels. Meta-analysis Research Group on the Diagnosis of Diabetes Using Glycated Hemoglobin Levels. JAMA 276 (1996) 1246-1252
18. Rowley K.G., Daniel M., and O'Dea K. Screening for diabetes in Indigenous populations using glycated hemoglobin: sensitivity, specificity, post-test likelihood and risk of disease. Diabet Med 22 (2005) 833-839
19. Rehfeld J.F., and Goetze J.P. The posttranslational phase of gene expression: new possibilities in molecular diagnosis. Curr Mol Med 3 (2003) 25-38
20. Goetze J.P., Kastrup J., Pedersen F., and Rehfeld J.F. Quantification of pro-B-type natriuretic peptide and its products in human plasma by use of an analysis independent of precursor processing. Clin Chem 48 (2002) 1035-1042
21. Goetze J.P., Mogelvang R., Maage L., Scharling H., Schnohr P., Sogaard P., et al. Plasma pro-B-type natriuretic peptide in the general population: screening for left ventricular hypertrophy and systolic dysfunction. Eur Heart J 27 (2006) 3004-3010
22. Lang R.M., Bierig M., Devereux R.B., Flachskampf F.A., Foster E., Pellikka P.A., et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18 (2005) 1440-1463
23. Devereux R.B., Alonso D.R., Lutas E.M., Gottlieb G.J., Campo E., Sachs I., et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57 (1986) 450-458
24. Du Bois D., and Du Bois E.F. A formula to estimate the approximate surface if height and weight be known. Arch Intern Med 17 (1916) 863-871
25. Devereux R.B., Dahlof B., Levy D., and Pfeffer M.A. Comparison of enalapril versus nifedipine to decrease left ventricular hypertrophy in systemic hypertension (the PRESERVE trial). Am J Cardiol 78 (1996) 61-65
26. Mogelvang R., Goetze J.P., Schnohr P., Lange P., Sogaard P., Rehfeld J.F., et al. Discriminating between cardiac and pulmonary dysfunction in the general population with dyspnea by plasma pro-B-type natriuretic peptide. J Am Coll Cardiol 50 (2007) 1694-1701
27. Troughton R.W., Prior D.L., Pereira J.J., Martin M., Fogarty A., Morehead A., et al. Plasma B-type natriuretic peptide levels in systolic heart failure: importance of left ventricular diastolic function and right ventricular systolic function. J Am Coll Cardiol 43 (2004) 416-422
28. Vinereanu D., Lim P.O., Frenneaux M.P., and Fraser A.G. Reduced myocardial velocities of left ventricular long-axis contraction identify both systolic and diastolic heart failure-a comparison with brain natriuretic peptide. Eur J Heart Fail 7 (2005) 512-519
29. Vasan R.S., Benjamin E.J., Larson M.G., Leip E.P., Wang T.J., Wilson P.W., et al. Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study. JAMA 288 (2002) 1252-1259
30. Kirkpatrick J.N., Vannan M.A., Narula J., and Lang R.M. Echocardiography in heart failure: applications, utility, and new horizons. J Am Coll Cardiol 50 (2007) 381-396
31. Ommen S.R., Nishimura R.A., Appleton C.P., Miller F.A., Oh J.K., Redfield M.M., et al. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: s comparative simultaneous Doppler-catheterization study. Circulation 102 (2000) 1788-1794
32. Kidawa M., Coignard L., Drobinski G., Krzeminska-Pakula M., Thomas D., Komajda M., et al. Comparative value of tissue Doppler imaging and m-mode color Doppler mitral flow propagation velocity for the evaluation of left ventricular filling pressure. Chest 128 (2005) 2544-2550
33. Firstenberg M.S., Levine B.D., Garcia M.J., Greenberg N.L., Cardon L., Morehead A.J., et al. Relationship of echocardiographic indices to pulmonary capillary wedge pressures in healthy volunteers. J Am Coll Cardiol 36 (2000) 1664-1669
34. Zile M.R., and Brutsaert D.L. New concepts in diastolic dysfunction and diastolic heart failure: part I: diagnosis, prognosis, and measurements of diastolic function. Circulation 105 (2002) 1387-1393
35. Yip G.W., Zhang Y., Tan P.Y., Wang M., Ho P.Y., Brodin L.A., et al. Left ventricular long-axis changes in early diastole and systole: impact of systolic function on diastole. Clin Sci (Lond) 102 (2002) 515-522
36. Redfield M.M., Rodeheffer R.J., Jacobsen S.J., Mahoney D.W., Bailey K.R., and Burnett J.C. Jr. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 40 (2002) 976-982
37. McDonagh T.A., Holmer S., Raymond I., Luchner A., Hildebrandt P.R., and Dargie H.J. NT-proBNP and the diagnosis of heart failure: a pooled analysis of three European epidemiological studies. Eur J Heart Fail 6 (2004) 269-273
38. Wu A.H. Serial testing of B-type natriuretic peptide and NTpro-BNP for monitoring therapy of heart failure: the role of biologic variation in the interpretation of results. Am Heart J 152 (2006) 828-834
39. Balion C.M., McKelvie R.S., Reichert S., Santaguida P., Booker L., Worster A., et al. Monitoring the response to pharmacologic therapy in patients with stable chronic heart failure: is BNP or NT-proBNP a useful assessment tool?. Clin Biochem 41 (2008) 266-276
40. Fang Z.Y., Leano R., and Marwick T.H. Relationship between longitudinal and radial contractility in subclinical diabetic heart disease. Clin Sci (Lond) 106 (2004) 53-60
41. Przewlocka-Kosmala M., Kosmala W., and Mazurek W. Left ventricular circumferential function in patients with essential hypertension. J Hum Hypertens 20 (2006) 666-671